Energy storage is currently one of the most significant technological challenges globally, and supercapacitor is a prominent candidate over batteries due to its ability for fast charging and long lifetime. Supercapacitors typically use porous carbon as electrodes, because of both the high conductivity and surface area of the material. However, the state-of-the-art porous carbon described in the literature uses toxic chemicals and complex procedures that enhance costs and pollute the environment. Thus, a more sustainable procedure to produce porous carbon is highly desirable. In this context, xerogel-like carbons were prepared by a new, cheap, simple route to polymerization reactions of tannin-formaldehyde in a bio-oil by-product. Using bio-oil in its natural pH allowed a cost reduction and avoided using new reactants to change the reactional medium. Textural properties and electrochemical performances were improved by fast activating the material per 20 min. The non-activated carbon xerogel presented a capacitance of 92 F/g, while the activated one had 132 F/g, given that 77% of the components used are eco-friendly. These results demonstrate that renewable materials may find applications as carbon electrodes for supercapacitors. Overhauling the synthesis route with a different pH or replacing formaldehyde may enhance performance or provide a 100% sustainable carbon electrode.

Having high porosity and biocompatibility, carbon-based materials are promising candidates for tissue engineering applications, particularly as substitutes for biological tissues. This study investigates the growth and viability of osteoblasts on four different activated carbon (AC) materials and correlates biological responses with their physicochemical and morphological properties. Two materials derived from non-renewable sources—AC1, a laboratory-synthesized carbon derived from anthracite, and AC3, a commercial activated carbon (Norit GCN 830) derived from coal—and two commercial activated carbons derived from renewable sources—peat, AC2 (Norit PK1-3), and wood, AC4 (ROX 0.8)—are studied. Results showed that AC1 exhibited the highest porosity (3072 m²/g), with higher phenolic and oxygen-containing surface groups but lower cell viability. In contrast, AC2, AC3, and AC4 displayed lower porosity compared to AC1 (755, 1040, and 1083 m²/g, respectively) and fewer surface phenolic groups but sustained osteoblast proliferation. Notably, AC4 demonstrated superior performance, characterized by regions of fibrous surface, pores in the meso- and microscale range (<50 nm), and enhanced cell viability and proliferation. AC2 also showed favorable results, ranking second for cell growth support. These findings suggest that biomass-derived ACs, particularly AC4 and AC2, provide favorable environments for osteoblast viability and proliferation. AC costs were estimated at 15 to 38 times lower than those for hydroxyapatite and bioceramics, which are widely used for bone cell growth. Thus, ACs made from renewable sources are promising candidates for tissue engineering applications, offering sustainable and effective alternatives for biomedical use.

Autogenous grafts remain the gold standard for repairing extensive maxillofacial bone defects, but their associated morbidity motivates the search for alternative strategies in tissue bioengineering. Deciduous dental pulp stem cells (DDPSCs) represent a promising cell source due to their accessibility, multipotency, and osteogenic potential, while nanostructured carbonated hydroxyapatite (cHA) microspheres exhibit biochemical similarity to bone mineral and favorable bioabsorption. This study investigated the osteogenic response induced by the association of DDPSCs with cHA in a rat calvaria critical-size defect model. DDPSCs were expanded, seeded onto cHA microspheres, and characterized in vitro prior to bilateral implantation in 12 Wistar rats, with each animal receiving cHA + DDPSC on the right defect and acellular cHA on the left. After 60 and 90 days, histological and histomorphometric analyses revealed new bone formation in both groups, predominantly from the defect margins toward the center. At 60 days, no significant difference in newly formed bone was observed between groups (p = 0.249). At 90 days, the DDPSC + cHA group demonstrated significantly greater bone formation compared with acellular cHA (median 40.70 vs. 11.10 histomorphometric points; p = 0.028) and significant reduction in connective tissue (p = 0.028). Complete scaffold resorption was observed in all DDPSC-treated defects at 90 days, whereas residual biomaterial persisted in the cHA group (p = 0.015), indicating progressive cHA resorption over time. These findings suggest that combining DDPSCs with cHA enhances bone regeneration and that this synthetic, bioabsorbable scaffold represents a promising strategy for future applications in bone tissue engineering.